CoChat

Immunoadsorption in dilated cardiomyopathy: long‐term reduction of cardiodepressant antibodies

Trimpert, Christiane, Herda, Lars R., Eckerle, Lars G., Pohle, Susanne, Müller, Carina, Landsberger, Martin, Felix, Stephan B., Staudt, Alexander · 2010 · European Journal of Clinical Investigation
Cited by 51

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Eur J Clin Invest 2010; 40 (8): 685–691 Background Disturbances of humoral immunity have been described in dilated cardiomyopathy (DCM), and a number of antibodies against cardiac cell proteins have been identified. Previous studies showed that immunoadsorption therapy with subsequent IgG substitution (IA/IgG) enhances cardiac function, and that removal of cardiodepressant antibodies may represent one essential mechanism of this therapy. The long‐term effect of IA/IgG on the level of cardiodepressant antibodies remains to be elucidated. Methods A total of 17 patients with DCM were observed up to 12 months after IA/IgG. Echocardiographic measurements were performed at baseline, 3, 6 and 12 months after therapy. Cardiodepressant antibodies were detected by incubation of rat cardiomyocytes with purified patients’ IgG and recording of contractility and Ca 2+ ratio. Results In contrast to patients without cardiodepressant antibodies before IA/IgG, patients with negative inotropic antibodies showed an improvement of left ventricular ejection fraction (LVEF) from 33·8 ± 1·7% to 44·7 ± 2·7%; 44·5 ± 2·3% and 51·8 ± 1·7% after 3, 6 and 12 months (P < 0·001 vs. baseline, P < 0·05 vs. LVEF of non‐cardiodepressant group). Immediately after IA/IgG therapy, no cardiodepressant effects of patients’ IgG on isolated cardiomyocytes were detectable, and this effect remained diminished until 6 months after IA/IgG (P < 0·001 for contractility and Ca 2+ ratio). Compared with the levels after 3 and 6 months, cardiodepressant antibodies reoccured after 12 months (P = 0·067 for contractility, P < 0·05 for Ca 2+ ratio vs. 6 months after IA/IgG). However, the negative inotropic reaction is still diminished compared with the reaction before IA/IgG. Conclusion IA/IgG therapy induces long‐term reduction of negative inotropic antibodies. After 12 months, however, re‐increase of negative inotropic antibodies cannot be excluded.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2362.2010.02314.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 51

Metadata

Authors
Trimpert, C., Herda, L. R., Eckerle, L. G., Pohle, S., Müller, C., Landsberger, M., Felix, S. B., & Staudt, A.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
2010-07-09
Volume
40
Issue
8
Pages
685-691
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W2118390112
Cited by
51
References
5
FWCI
2.45
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunoadsorption in dilated cardiomyopathy: long‐term reduction of cardiodepressant antibodies. https://app.cochat.ai/papers/10.1111/j.1365-2362.2010.02314.x
The paper
Trimpert, C., Herda, L. R., Eckerle, L. G., Pohle, S., Müller, C., Landsberger, M., Felix, S. B., & Staudt, A. (2010). Immunoadsorption in dilated cardiomyopathy: long‐term reduction of cardiodepressant antibodies. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2010.02314.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.